Synergia Energy Ltd Overview
Synergia Energy is a Perth-headquartered, AIM-quoted nano-cap upstream oil and gas company whose economic value now rests almost entirely on one asset: a 50% participating interest in the onshore Cambay Production Sharing Contract (PSC) in Gujarat, India. It is joint operator there alongside Antelopus Selan Energy Ltd, which funds and leads a US$20 million work programme under a 2024 farm-out. Formerly Oilex Ltd, the company spent two decades as a frontier and junior explorer across India, the Timor Sea, Indonesia, Australia and the UK. It rebranded in 2022 around "responsible gas" and carbon capture and storage (CCS), and in 2025–26 it attempted to exit Cambay entirely for up to US$14 million. That sale collapsed in February 2026. In June 2026 Synergia announced it would relinquish its UK Camelot CCS licence. What remains is a cash-constrained, going-concern-qualified company with modest oil production, a large stated Eocene gas resource, a nascent Cambay CCS concept, and dependence on its largest shareholder for working capital.
What the company does
Synergia Energy explores for, appraises, develops, produces and sells hydrocarbons, mainly natural gas and associated oil and condensate. It also develops CCS projects. Its business description, as reproduced by Morningstar and AJ Bell, has three parts:
-
a focus on "responsible" gas production;
-
identifying natural gas assets with development potential in gas-producing basins;
-
an aim to contribute to CO2 emission reduction through CCS.
Data vendors note that the majority of revenue comes from India.
In practice, as of October 2026, the operating business consists of:
-
Cambay PSC (onshore Gujarat, India) — 50% participating interest, joint operator. Oil production comes mainly from worked-over legacy wells (C-64, C-74, C-08). There are small gas volumes from the horizontal multi-stage fracked well C-77H. A new Oligocene gas discovery test was made at C-78, and the Eocene-targeted C-79 well is planned to spud in late November 2026.
-
Cambay CCS Scheme (India) — 100% interest, operator. This is a pre-FID concept to inject CO2 into the thick Olpad Formation beneath the Cambay field. The British Geological Survey joined the consortium in October 2024. A pilot was proposed for calendar 2026, subject to Indian regulatory engagement.
-
Medway Hub Camelot CCS Project (UK Southern North Sea, licence CS019) — 50%, operator. Being relinquished. On 16 June 2026 the company announced it would give up its interest, citing legacy well-integrity uncertainties.
Business and revenue model
| Revenue model component | Share of revenue | Commentary |
|---|---|---|
| Product sales — crude oil and condensate (India) | Majority (exact split not disclosed) | Sold within India under PSC terms. Synergia's net share fell after the 2024 farm-out. |
| Product sales — natural gas (India) | Minority | Very small volumes, e.g., 39 Mcf/d gross from C-77H in April 2026 |
| Services, subscriptions, licensing | 0% | Not applicable |
| CCS revenue | 0% | Pre-revenue. No storage contracts. |
| One-off gains on asset transactions | Not revenue, but dominant P&L driver | A$8.4m gain on the Cambay farm-out in FY2025 drove the only profitable year in the period |
Revenue is small. Gas and oil sales were A$292,179 in FY2025, versus A$638,457 in FY2024, and A$116,469 in H1 FY2026. Value creation has historically come from asset transactions (farm-outs, sales), not operating cash flow.
Value-chain position, customers and end-markets
Synergia sits purely in the upstream segment: exploration, appraisal, development and production. It has no midstream, refining or marketing assets. Customers are Indian domestic offtakers of crude and gas from the Cambay field. Named counterparties are not publicly disclosed in the sources reviewed. Its end-market is the Indian domestic energy market, which is structurally short of oil and gas and import-dependent. On the CCS side, the targeted end-market was industrial emitters around the UK Thames/Medway area (now abandoned) and, prospectively, Gujarat industrial emitters.
Independent characterisation
Synergia is best understood as a single-asset, sub-scale, financially fragile junior whose equity is effectively a call option on the Cambay Eocene tight-gas resource. The company itself cites a P50 gas figure of around 206 Bcf, as reported by Kalkine in July 2026. That figure is the company's own claim, and its classification (reserve versus contingent resource) should be checked in the competent-person report.
The company has repeatedly re-framed its strategy:
-
frontier explorer (Oilex, 2000s–2010s);
-
"Super Basins" junior (late 2010s);
-
"responsible gas plus CCS double play" (2022–2025);
-
"exit and return capital" (2025);
-
back to "focused Cambay developer plus E&P opportunities" (June 2026).
Each pivot has followed a funding or transaction setback. The 2024 Selan farm-out is the company's most consequential achievement in a decade. It transferred most of the capital burden for Cambay to a better-funded partner.
Strategy
Evolution of stated strategy
| Period | Stated strategy theme (paraphrased) | Source |
|---|---|---|
| Late 2010s (Oilex) | Focus on "Super Basins" open to juniors, with supportive regulators, rich open-file data and low-cost entry points | Sharecast legacy profile |
| 2022–2024 | "Responsible gas" production plus CCS: develop Cambay gas and become a CO2-reduction contributor via CCS (Medway Hub Camelot; Cambay CCS) | Company description (Morningstar / AJ Bell) |
| FY2025 Annual Report (Oct 2025) | Complete the Cambay sale, return a substantial part of the proceeds to shareholders, then reset strategy toward CCS development and new value-accretive opportunities | FY2025 Annual Report RNS; Alliance News |
| H1 FY2026 report (Mar 2026) | Strategic review of Cambay after the failed sale; seek a new Camelot partner; engage Indian regulators on the Cambay CCS pilot | Interim Report, 26 Mar 2026 |
| 16 Jun 2026 | Relinquish Camelot; refocus on developing Cambay and assessing additional E&P opportunities; retain CCS exposure via Cambay CCS | RNS, 16 Jun 2026 |
Initiatives in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Status (Oct 2026) |
|---|---|
| Selan-funded US$20m Cambay work programme (workovers; new vertical wells C-78, C-79; horizontal frac well) | Ongoing. C-78 tested gas (Jan 2026). C-79 spud late Nov 2026 (est.). |
| C-77H artificial lift | Implemented (2024–25); low gas rate (39 Mcf/d, Apr 2026) |
| Legacy-well workover programme (C-64, C-74, C-08) | Completed; oil production lifted to roughly 150–195 bopd gross at peaks |
| Sale of remaining 50% Cambay to Selan (up to US$14m) | Failed (Feb 2026); US$0.5m retained |
| Planned AIM cancellation (tied to sale) | Rejected by shareholders / moot (Dec 2025) |
| Capital return to shareholders | Contingent on sale; no longer applicable |
| Camelot CCS phasing (two phases, first injection 2030/31) | Abandoned with relinquishment (Jun 2026) |
| Cambay CCS pilot (with BGS) | Pre-pilot; regulatory engagement continuing |
| Cost reduction / board slimming | Mark Bolton departure; management has stressed cost discipline |
| Working-capital facility | US$0.7m Republic loan (Apr 2026) |
Medium-term targets / guidance
The company has no quantified medium-term financial guidance: no production, revenue, capex or margin targets. The only dated operational guidance is the C-79 spud, estimated for late November 2026.
Products & Services
Synergia sells commodities, not branded products. Its "portfolio" is a set of assets and projects, catalogued below.
Cambay PSC — Onshore Gujarat, India (Synergia 50% PI, joint operator; partner Antelopus Selan Energy Ltd 50%, lead operator)
| Attribute | Detail |
|---|---|
| Description | Mature onshore oil and gas field in the Cambay Basin, with shallow oil zones and a deep, tight Eocene gas/condensate reservoir |
| Key reservoirs | Eocene (tight gas, requires hydraulic fracturing); Oligocene (OS-II zone gas tested at C-78); shallower oil zones |
| Resource claim | Company cites P50 Eocene gas of about 206 Bcf. Classification should be checked in the CPR. |
| Producing wells (2025–26) | C-64 and C-74 (oil; worked over Oct 2025 with sucker rod pumps); C-08 (oil; worked over May 2026, about 30 bopd); C-77H (gas, horizontal multi-stage fracked well; artificial lift installed; 39 Mcf/d in Apr 2026); C-19z (existing Eocene producer near the planned C-79) |
| Recent production (gross) | About 40 bopd stabilised (Jan 2026); about 195 bopd (early Mar 2026); 148 bopd (Apr 2026); C-08 adds about 30 bopd (Jun 2026). Production is volatile and from a small well count. |
| Recent drilling | C-78: drilled, cased, perforated over 5 m in the Oligocene OS-II zone; gas shown during clean-up; under pressure observation (Jan 2026) |
| Planned drilling | C-79: Eocene primary target near C-19z; vertical/deviated well with hydraulic fracking; DEEP Industries rig; spud estimated late Nov 2026 |
| Farm-out economics | Selan funds a US$20m work programme: workovers of C-70 and C-63, two vertical wells, and one multi-stage fracked horizontal well. Synergia received a US$2.5m lump sum for past costs. |
| Target customer | Indian domestic crude and gas buyers (not named) |
| Pricing | Indian domestic pricing under PSC terms (specifics not disclosed) |
Cambay CCS Scheme — India (Synergia 100%, operator)
| Attribute | Detail |
|---|---|
| Concept | Capture CO2 from regional emitters, pipeline it to a CCS hub on the Cambay field, and inject it into the Olpad Formation for permanent storage |
| Storage formation | Olpad Formation, up to about 1 km thick in the Cambay Basin. Company believes it could form a national-scale CO2 storage resource. |
| Partners | British Geological Survey joined the consortium (Oct 2024); other consortium members not fully disclosed |
| Stage | Pre-pilot. Pilot proposed for calendar 2026, subject to regulatory engagement. No pilot start announced at dossier date. |
| Pricing / revenue model | Not disclosed (likely storage tariff or carbon-credit model if developed) |
Medway Hub Camelot CCS Project — UK Southern North Sea (licence CS019; Synergia 50%, operator; partner Harbour Energy 50%) — being relinquished
| Attribute | Detail |
|---|---|
| Concept | Store CO2 from Thames/Medway industrial emitters in the depleted Camelot gas field area |
| Phasing | Split into two phases to reduce risk and cost; initial injection targeted 2030/2031 (FY2025 Annual Report) |
| Key issue | Legacy wells drilled about 50 years ago and abandoned with open-hole sections in the Leman Sandstone and Zechstein. There is uncertainty over abandonment records and 1970s logs. |
| Regulatory | Legacy well integrity risk assessment submitted to NSTA in Nov 2025; reviewed at an NSTA workshop on 9 Jun 2026; work-programme delay previously agreed with NSTA |
| Partner status | Harbour Energy (successor to Wintershall Dea) gave notice of withdrawal on 28 Nov 2024. No replacement partner was found. |
| Outcome | 16 Jun 2026: Synergia announced relinquishment. Harbour reportedly also expected to relinquish. |
Historical / divested portfolio (for completeness)
| Asset | Country | Status | Notes |
|---|---|---|---|
| Cooper-Eromanga Basin interests | Australia | Divested to Armour Energy (2022) | Cited as a reason for ASX delisting |
| Bhandut field † | India | Legacy interest | Historical Gujarat asset alongside GSPC |
| JPDA 06-103 † | Timor Sea | Terminated (mid-2010s) | Frontier offshore; regulatory dispute |
| West Kampar PSC † | Indonesia | — | Historical |
| Canning Basin permits † | Australia | Exited | Historical |
| UK exploration interests † | UK | Not current | Pre-CCS UK activity |
Financial Narrative
Sources: FY2022 and FY2023 figures from FY2023 results (Alliance News, 21 Sep 2023) and Fintel's quarterly data. FY2024 and FY2025 from the FY2025 Annual Report summary RNS (7 Oct 2025) and Alliance News (Oct 2025). Half-year data from interim reports (13 Mar 2025, 26 Mar 2026) and Google Finance (Dec 2023). All figures in A$ millions unless stated. Figures computed from these inputs are labelled "derived".
Income statement
Revenue CAGR FY2022–FY2025 (derived): about +27% a year, from A$0.141m to A$0.292m. This figure is not meaningful. It spans a peak in FY2023 and a structural halving of Synergia's working interest in FY2025.
Commentary:
FY2022–FY2023: The company carried 100% of Cambay costs while restarting and stimulating wells. Revenue rose about ninefold, but cost of sales more than tripled, so losses widened to A$5.4m before tax. Management nonetheless described the outlook as very positive at the time.
FY2024: The net loss narrowed to A$2.8m as farm-out negotiations progressed.
FY2025: The A$8.4m farm-out gain produced a reported net profit of A$5.0m. Underlying operations remained loss-making.
Half-year income statement: notes and sources
Sources: Google Finance (Dec 2023 half); interim report 13 Mar 2025; interim report 26 Mar 2026 and Alliance News coverage. The H1 FY2025 pre-tax figure (A$6.3m, Alliance News) and net figure (A$10.59m, interim report as summarised by ticker.app) are reported as given and are not fully reconcilable from public summaries.
Balance sheet
Commentary:
-
At 30 June 2025 the company reported no unsecured borrowings. All prior debt had been extinguished through repayments and equity conversions.
-
Cash fell from A$1.21m (June 2025) to A$0.81m (December 2025).
-
In April 2026 the company re-levered with the US$0.7m Republic facility.
-
Net assets of about A$18m are dominated by the carrying value of Cambay. That value was underpinned by the US$14m sale price until February 2026, and could be impaired in FY2026 now that the sale has failed.
-
The gap between book equity (about A$18m) and market capitalisation (about £1.6m, roughly A$3m) shows that the market heavily discounts the realisability of Cambay value.
-
Working capital, goodwill and the detailed debt split were not verifiable. The company has no goodwill of note.
Cash flow
No dividends have been paid and there is no buyback programme.
Pattern: Operating cash flow has been consistently negative. The company is funded by equity placements (e.g., £750,000 in Feb 2025; issues in Nov 2024), convertible loans (£0.65m in Feb 2023), asset-transaction cash (US$2.5m past-cost lump sum from Selan in 2024; US$0.5m sale deposit in Aug 2025) and shareholder loans (US$0.7m in Apr 2026).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment / Region Details
| Segment / Region | Contents | Products | Revenue | Operating result |
|---|---|---|---|---|
India — Cambay PSC | 50% PI (joint operator) in Cambay field, Gujarat | Crude oil, condensate, natural gas | 100% of group sales revenue (company reports revenue only from India) | — |
India — Cambay CCS | 100% concept-stage CO2 storage scheme (Olpad Formation) | None (pre-revenue) | 0 | Pre-revenue costs; not separately disclosed |
UK — Camelot CCS (CS019) | 50% operated carbon storage licence; being relinquished | — | 0 | Licence and study costs; not separately disclosed |
Corporate | Perth head office, listing costs | — | 0 | Corporate overhead |
“—” = not publicly disclosed.
Revenue by Segment and Segment Margins & Growth (%)
| Segment | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
India oil and gas sales (AUD Mn) | — | 0.141 | 1.30 | 0.638 | 0.292 |
UK CCS revenue (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
India % of total revenue | — | 100 | 100 | 100 | 100 |
YoY growth India sales (%) | — | — | 822 | -51 | -54 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue — oil and gas sales (AUD Mn) | — | 0.141 | 1.30 | 0.638 | 0.292 |
Cost of sales (AUD Mn) | — | 0.754 | 2.6 | — | — |
Gross profit (AUD Mn, derived) | — | -0.613 | -1.30 | — | — |
Gain on Cambay farm-out (AUD Mn) | — | — | — | — | 8.4 |
Pre-tax profit (loss) (AUD Mn) | — | -2.1 | -5.4 | — | — |
Net profit (loss) after tax (AUD Mn) | — | — | -5.38 | -2.8 | 5.0 |
Dividends per share (AUD) | 0 | 0 | 0 | 0 | 0 |
Gross margin (%, derived) | — | -435 | -100 | — | — |
Net margin (%, derived) | — | — | -414 | -439 | 1,712 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement
| Metric | H1FY2024 | H1FY2025 | H1FY2026 |
|---|---|---|---|
Revenue (AUD Mn) | 0.177 | 0.156 | 0.116 |
Pre-tax profit (loss) (AUD Mn) | — | 6.3 | -0.575 |
Net profit (loss) (AUD Mn) | -1.03 | 10.59 | -0.575 |
EBITDA (AUD Mn) | -1.12 | — | — |
Operating expense (AUD Mn) | 0.929 | — | — |
Balance Sheet
| Metric | FY2024 | FY2025 |
|---|---|---|
Cash at bank (AUD Mn) | 1.07 | 1.21 |
Total borrowings (AUD Mn) | — | 0 |
Net assets / equity (AUD Mn) | 9.96 | 18.95 |
Balance Sheet and Share Count (billions)
| Metric | Dec2023 | Dec2025 |
|---|---|---|
Cash and short-term investments (AUD Mn) | 1.79 | 0.81 |
Total assets (AUD Mn) | 19.79 | — |
Total liabilities (AUD Mn) | 8.26 | — |
Total equity (AUD Mn) | 11.53 | 17.96 |
Shares outstanding (billions) | 10.50 | 15.6 |
Cash Flow
| Metric | H1FY2024 |
|---|---|
Cash from operations (AUD Mn) | -0.677 |
Cash from investing (AUD Mn) | -0.288 |
Cash from financing (AUD Mn) | 1.39 |
Free cash flow (AUD Mn) | -1.15 |
Net change in cash (AUD Mn) | 0.425 |
Financial Analysis
| Ratio | Value | Basis / Source |
|---|---|---|
ROE | -9.59% | MarketInOut (TTM, Jun 2026) |
ROA | -7.68% | MarketInOut (TTM, Jun 2026) |
ROIC | -14.07% | MarketInOut (TTM, Jun 2026) |
Debt / equity | 0.00 at Jun 2025; small positive after Apr 2026 loan | FY2025 AR; RNS 7 Apr 2026 |
Net debt / EBITDA | Not meaningful (negative EBITDA) | — |
Asset turnover | About 0.015x (FY2025 revenue / net assets, derived) | Derived |
Cash conversion cycle | Not disclosed / not meaningful | — |
Altman Z-score | -9 (distress zone) | MarketInOut |
Piotroski F-score | 4/9 | MarketInOut |
Revenue by Region
| Region | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
India revenue (AUD Mn) | — | 0.141 | 1.30 | 0.638 | 0.292 |
United Kingdom revenue (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Australia revenue (AUD Mn) | — | 0 | 0 | 0 | 0 |
Change by Period
| Period | Change | Source / Date |
|---|---|---|
1 month | -16.7% | MarketInOut, as of 17 Jun 2026 |
6 months | +26.6% | MarketInOut, as of 17 Jun 2026 |
1 year | -49.0% | MarketInOut, as of 17 Jun 2026 |
1 year (earlier snapshot) | -35% | Alliance News, Mar 2026 |
3 years | -86% | Simply Wall St (earlier snapshot, date not specified) |
5 years | -77% | Simply Wall St (earlier snapshot, date not specified) |
Price point | Value | Date |
Recent quote | About 0.0105p (market cap about £1.64m) | lse.co.uk (2026 snapshot) |
Feb 2026 | About 0.01p | Fintel, 9 Feb 2026 |
Mar 2026 | 0.013p | Alliance News, 26 Mar 2026 |
Oct 2025 | 0.020p | Alliance News, 7 Oct 2025 |
| 2023 | 0.12–0.13p | Alliance News / Google Finance |
Dec 2022 (final ASX) | A$0.001 | InvestSMART |
Share Count (billions)
| Metric | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Representative share price (GBp) | 0.12 | — | 0.02 | 0.01 |
Shares outstanding (billions) | — | 10.50 | — | 15.6 |
Valuation Multiples
| Multiple | Synergia | Comment |
|---|---|---|
P/E | n/m | Loss-making excluding one-offs |
EV/EBITDA | -1.19x | MarketInOut (negative EBITDA; not meaningful) |
EV/Sales | 8.66x | MarketInOut |
P/B | About 0.15–0.2x (derived: about A$3m market cap vs A$17.96m net assets at Dec 2025) | Deep discount to book |
Peer comparison | Not compiled | — |
Capital Markets
| Item | Detail |
|---|---|
Analyst consensus | No major broker coverage (Market Index). Simply Wall St cites 2 covering analysts. Fintel shows a 0.95 GBX one-year "target", which is roughly 90 times the current price, appears stale or erroneous, and should be disregarded. SP Angel has published flash notes (e.g., Jul 2025, "Proposed $14m Cambay sale unlocks value"). |
Dividend history / policy | No dividends ever paid. A planned capital return contingent on the Cambay sale lapsed. |
Credit ratings | None (Moody's, S&P, Fitch: not rated) |
Debt maturity profile | US$0.7m Republic facility. Tranche 1 of US$350k available from 20 Apr 2026, repayable within 12 months of first drawdown (by about Apr 2027 if drawn at availability). Tranche 2 of US$350k from no earlier than 1 Sep 2026 by agreement. 7.5% interest; unsecured. Drawdown status not disclosed. |
Historical financing pattern | 2015 placements (A$0.041); 2018 (0.19p); 2020 (A$0.00266); 2023 convertible (0.08p); Nov 2024 equity issue and option exercise; Feb 2025 £750k raise |
Analyst Conclusions
Management guidance
No financial guidance has been given. Operational guidance:
-
C-79 Eocene fracked well to spud in late November 2026.
-
Continued workovers to sustain oil output.
-
Strategic review of Cambay options, including potential sale or partnership.
-
Cambay CCS regulatory engagement.
-
Assessment of new E&P opportunities.
Consensus
None is available.
Bull case
-
Asymmetric resource leverage: A market cap of about £1.6m against a company-cited P50 gas resource of about 206 Bcf and a recent arm's-length price benchmark of up to US$14m for the same 50% interest. If C-79 flows commercially, the gap could close sharply.
-
Carried exposure: Selan's US$20m programme funds the key wells (C-78, C-79, horizontal frac), so Synergia gets drilling upside without proportional capex.
-
Simplified story, lower liabilities: Exiting Camelot removes UK legacy-well exposure and non-core spend. Workovers have demonstrably lifted oil output to roughly 150–195 bopd gross.
Bear case
-
Funding cliff: Cash of A$0.81m (Dec 2025), a going-concern warning, and a 12-month related-party loan make a dilutive raise likely across about 15.6 billion shares.
-
Monetisation credibility damaged: The only buyer, which is also the operator, could not complete the purchase. A US$14m valuation is now unproven, and a FY2026 impairment against A$18m book value is possible.
-
Technical track record: Prior fracked Eocene wells (e.g., C-77H at 39 Mcf/d) underwhelmed. C-79 may repeat this, and revenue is in steady decline (FY2023 A$1.30m → H1 FY2026 A$0.116m).
Key catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable |
|---|---|
| Oct–Dec 2026 | FY2026 Annual Report: impairment, going-concern wording, cash at 30 Jun 2026 |
| 27 Nov 2026 (vendor calendar) | AGM: resolutions on capital authorities and board |
| Late Nov 2026 onward | C-79 spud, frac and flow-test results |
| Ongoing | C-78 Oligocene gas monetisation plan |
| Ongoing | Monthly production updates (target: sustain over 150 bopd gross) |
| H1 2027 | Drawdown and repayment of the Republic loan; any equity raise |
| Any time | New Cambay sale or partnership; Selan relationship developments |
| Any time | Confirmation of Camelot relinquishment completion and any residual obligations |
| Mar 2027 | H1 FY2027 interim report |
Analyst verdict
Synergia Energy, formerly Oilex, is a 29-year-old junior that has never become self-funding. Over two decades it cycled through frontier exploration, a "Super Basins" strategy, a gas-plus-CCS "double play" and a planned exit. The only consistent constant is the Cambay field in Gujarat. That asset is real and has a cited resource of about 206 Bcf P50. Its development is carried by Antelopus Selan through a US$20m work programme, and in July 2025 an arm's-length counterparty agreed to pay up to US$14m for Synergia's remaining 50%. Against a market capitalisation of roughly £1.6m, those facts describe a deeply discounted option.
The discount exists for documented reasons. The Selan sale collapsed in February 2026 when its buyer's controlling shareholder declined to proceed. The UK Camelot CCS project, the cornerstone of the 2022 rebrand, is being relinquished. Cash stood at A$0.81m at December 2025, and auditors flagged a material going-concern uncertainty. The company now depends on a US$0.7m loan from its largest shareholder. Underlying revenue has fallen for three consecutive periods, and reported profit in FY2025 came entirely from a non-recurring farm-out gain.
The investment case is now binary and near-dated. The C-79 Eocene fracked well, expected to spud in late November 2026, is the single most important event in the company's recent history. A commercial result would underpin the resource, restore negotiating leverage with Selan or a new buyer, and potentially justify a value several multiples of today's price. A disappointing result would probably force heavily dilutive financing or a distressed sale. Meanwhile the FY2026 accounts may bring an impairment and renewed going-concern scrutiny.
Verdict: Highly speculative and suitable only for risk capital. Fundamental value exists on paper, but realisation depends on the drill bit, partner behaviour and financing. None of these is in Synergia's sole control.
Sources consulted (primary and secondary)
-
Synergia Energy RNS announcements (via LSE/lse.co.uk, Investegate, Proactive, Stockopedia, ticker.app, dfcfw.com mirrors): 4 Aug 2025; 7 Oct 2025 (FY2025 Annual Report summary); 1 Dec 2025; 29 Dec 2025; 22 Jan 2026; 9 Feb 2026; 26 Mar 2026 (Interim Report); 7 Apr 2026; 5 May 2026; 16 Jun 2026; 1 Oct 2026; 13 Mar 2025 (Interim Report); 4 Feb 2025; 23 Oct 2024; 28 Nov 2024
-
ASX filings: Appendix 3B notices (2015–2020); delisting announcements (17–30 Nov 2022; 23 and 30 Dec 2022)
-
Alliance News (via AJ Bell / MoneyAM): FY2023 results (21 Sep 2023); FY2025 results (Oct 2025); H1 FY2026 results (Mar 2026); delisting coverage (Nov–Dec 2022)
-
Sharecast (convertible loan, 22 Feb 2023; company profile); energy-pedia (loan agreement, 7 Apr 2026); Kalkine (24 Jul 2026 analysis); Josh Thompson commentary (Apr 2026)
-
Data vendors: Market Index; MarketInOut; Morningstar; PitchBook; Google Finance; Fintel; Simply Wall St; Investing.com; MarketBeat; roic.ai; AJ Bell key dates; InvestSMART
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure | Background / Prior roles | Age |
|---|---|---|---|---|
Roland Wessel | CEO and Executive Director (MD/CEO) | Since 2021 | Signs all 2024–2026 RNS as CEO; leads the CCS and Cambay strategy | 69 (Investing.com) |
Andrew Liam Darbyshire | CFO (Nov 2024) and Executive Director (4 Feb 2025) | Since Nov 2024 | ICAEW Fellow; qualified 2011 at Garbutt & Elliott; Grant Thornton audit; built finance at Getech Group plc from 2014, on its board from 2018; MMath, University of York | 42 at appointment (2024) |
Ashish Khare | Executive Director & Head of India Assets | Since 2016 | BE Chemical Engineering; leads Cambay operations | 51 (Investing.com) |
Jonathan (Joe) Salomon | Non-Executive Chairman | Board since 2015 (former Managing Director) | B App Sc (Geology), GAICD; long-serving MD of Oilex | 66 (Investing.com) |
Paul Haywood | Independent Non-Executive Director | Since 2017 | Not detailed in sources reviewed | 43 (Investing.com) |
Peter Heinz Schwarz | Independent Non-Executive Director | Since 2019 | Not detailed in sources reviewed | 73 (Investing.com) |
Stacey Britza | Non-Executive Director | Appointed May 2026 (RNS 12 May 2026) | Previously Synergia's Assistant (Company) Secretary | — |
Luke Phillips | Company Secretary | Current per MarketBeat | — | — |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context |
|---|---|---|
| 2021 | Roland Wessel (CEO) and Colin Judd (CFO and director) appointed | Post-Salomon management era |
23 Oct 2024 (eff. 4 Nov 2024) | Colin Judd steps down; Andrew Darbyshire appointed CFO | Finance transition |
4 Feb 2025 | Darbyshire joins board as Executive Director | Board strengthened ahead of the Cambay transaction |
5 May 2026 | Mark Bolton (NED, former CFO/Company Secretary) steps down | Cost/board refresh |
12 May 2026 | Stacey Britza appointed NED | Internal promotion |
Earlier | Company secretaries have included Mark Bolton (2017), Jack Rosagro (2022), Anshu Raghuvanshi (from 2023 per Investing.com) and Luke Phillips | Turnover in the secretarial role |
Governance Overview
| Feature | Assessment |
|---|---|
Board size | 7 directors (after the May 2026 changes): 3 executive, 4 non-executive |
Independence | 2 directors described as independent NEDs (Haywood, Schwarz). The Chairman is a former MD and is not independent by usual standards. Britza is a former employee. |
Chair / CEO separation | Yes (Salomon / Wessel) |
Committee structure | Not detailed in sources reviewed; typical AIM audit and remuneration committees expected |
Governance code | AIM Rule 26 requires adoption of a recognised code (likely QCA). |
Major Shareholders
| Holder | Stake | Date / Source |
|---|---|---|
Republic Investment Management Pte Ltd (Singapore) | About 12.4% | Apr 2026 (related-party loan commentary) |
Republic Investment Management Pte Ltd (historical) | 16.07% (1,324,249,116 shares) | 8 Jun 2022 (Market Index) |
TH Investments Pte Ltd | 1.95% (111,111,111 shares, historical) | Market Index (date of holding not specified) |
Other TR-1 notifications | Filed 24 Jun 2025, 21 Jul 2025, 14 Mar 2025, 5 Dec 2024. | RNS headlines |
Institutional ownership (top 10) | Not publicly disclosed in a compiled form. The register is predominantly UK retail via CREST depositary interests. | — |
Insider ownership | Darbyshire held no shares at appointment (2024/25). | RNS |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Relevance |
|---|---|---|
Cambay Basin onshore producers | Oil and Natural Gas Corporation (ONGC) | Dominant Cambay Basin operator |
Cambay Basin onshore producers | Gujarat State Petroleum Corp (GSPC) | Former Cambay partner; state player |
Cambay Basin onshore producers | Antelopus Selan Energy Ltd | JV partner, failed acquirer, and a consolidator of small Indian fields |
Cambay Basin onshore producers | Hindustan Oil Exploration Company (HOEC) | Indian independent with Cambay and other onshore assets |
Cambay Basin onshore producers | Sun Petrochemicals / Invenire Energy / other DSF-round awardees | Small-field operators |
Indian upstream (broader) | Oil India Ltd; Vedanta (Cairn Oil & Gas) | Capital, rigs and services competition |
Indian tight gas | ONGC (KG and Cambay tight programmes) | Technical and fracking service competition |
AIM micro-cap E&P (capital competition) | Europa Oil & Gas; Union Jack Oil; Egdon/peers; Coro Energy; Pantheon Resources | Competing for UK retail E&P capital |
UK CCS (historical) | Harbour Energy; Eni (Liverpool Bay); Perenco; Carbon Catalyst / other SNS licensees | Competitors for CO2 stores and emitter offtake (now moot) |
Peer Comparison FY2025
| Metric | Synergia (FY2025) | Antelopus Selan |
|---|---|---|
Revenue | A$0.29m | — |
Revenue growth | -54% | — |
Net margin | Distorted by one-off gain (+1,712%) | — |
Cambay exposure | 50% Cambay PSC | 50% Cambay PSC |
Recent Developments
--



